Skip to main content
. 2017 Feb 6;7:42016. doi: 10.1038/srep42016

Figure 2. Mortalin-overexpressing MDA-MB 231, U2OS and G361 cells show cancer stem cell characteristics.

Figure 2

Mortalin-overexpressing MDA-MB 231 cells show low level of CD24 and CD61 expression and high level of CD9 expression as compared to control cells (A). Mortalin-overexpressing U2OS cells showed low level of expression of CD61 and high level of expression of ABCG2, MRP1, CD133 and connexein as compared to control cells (B). Mortalin-overexpressing G361 cells showed high level of expression of CD9, MRP1, CD133 and ALDH1 (C).